The US direct-to-consumer laboratory testing market is projected to expand from 2,700 Million USD in 2020 to 9,200 Million USD by 2035. The steady year-on-year growth is driven by rising consumer awareness, improvements in testing technologies, regulatory support, and the proliferation of digital health platforms. Notably, rapid acceleration is observed from 2024 onward as major retailers and telehealth companies integrate diagnostics into their health offerings.
Read More - https://bussinessinsights.com/research-report/us-direct-to-consumer-laboratory-testing
By application, oncology leads with 27% of the market as cancer risk panels gain prominence for early detection and prevention. Cardiology testing captures 22% as cardiovascular health awareness increases. Infectious diseases testing is at 18%, in part due to the ongoing demand for at-home screening following the pandemic. Neurology comprises 13%, endocrinology holds 11%, and other applications together represent 9%. This breakdown emphasizes consumer interest in proactive disease risk assessment alongside wellness monitoring.
Request Free Sample- https://bussinessinsights.com/request/telecommunication/us-direct-to-consumer-laboratory-testing
Who are the key players in US Direct-to-Consumer Laboratory Testing industry?
The top 5 players in the US Direct-to-Consumer Laboratory Testing industry are 23andMe, Everlywell, LetsGetChecked, LabCorp, and Quest Diagnostics. These companies offer a range of testing services, from genetic and health testing to wellness screenings, providing consumers easy and direct access to laboratory results.
What is the US Direct-to-Consumer Laboratory Testing growth?
The US Direct-to-Consumer Laboratory Testing market has seen rapid growth, with Everlywell experiencing significant revenue increases in 2023 due to rising at-home health awareness, telehealth adoption, and expanded testing portfolios. Market momentum is driven by consumer demand for convenient, affordable, and private medical testing solutions.
Which segment accounted for the largest US Direct-to-Consumer Laboratory Testing share?
The health and wellness testing segment holds the largest market share in US DTC lab testing, led by demand for tests like food sensitivity, general wellness, and hormone testing. Everlywell and similar companies have popularized these offerings with user-friendly kits, contributing to their dominance in this application category.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com